Ardent Health Partners (NYSE:ARDT – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided EPS guidance of $1.23-1.37 for the period, compared to the consensus EPS estimate of $1.21. The company issued revenue guidance of $5.75-5.90 billion, compared to the consensus revenue estimate of $5.84 billion.
Wall Street Analysts Forecast Growth
ARDT has been the topic of a number of research reports. Citigroup began coverage on Ardent Health Partners in a research note on Monday. They issued a buy rating and a $21.00 price target on the stock. Royal Bank of Canada began coverage on Ardent Health Partners in a research report on Monday. They set an outperform rating and a $23.00 target price on the stock. Leerink Partnrs raised shares of Ardent Health Partners to a strong-buy rating in a research note on Monday. Morgan Stanley assumed coverage on Ardent Health Partners in a research note on Monday. They issued an overweight rating and a $27.00 price target for the company. Finally, Bank of America initiated coverage on Ardent Health Partners in a research report on Monday. They set a buy rating and a $22.00 price objective for the company. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of Buy and a consensus target price of $21.70.
Check Out Our Latest Analysis on ARDT
Ardent Health Partners Trading Down 0.1 %
About Ardent Health Partners
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Featured Stories
- Five stocks we like better than Ardent Health Partners
- How to invest in marijuana stocks in 7 steps
- Brinker International’s Price Dip is an Appetizing Entry Point
- What Are Trending Stocks? Trending Stocks Explained
- 3 Stocks That Could Beat the September Blues
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.